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The relative biological effectiveness for carbon, nitrogen, and oxygen ion beams 




The aim of this study was to measure the microdosimetric distributions of a carbon pencil beam 
scanning (PBS) and passive scattering system as well as to evaluate the relative biological effectiveness 
(RBE) of different ions, namely 12C, 14N, and 16O, using a silicon‐on‐insulator (SOI) microdosimeter with 
well‐defined 3D‐sensitive volumes (SV). Geant4 simulations were performed with the same experimental 
setup and results were compared to the experimental results for benchmarking. 
Method 
Two different silicon microdosimeters with rectangular parallelepiped and cylindrical shaped SVs, both 10 
μm in thickness were used in this study. The microdosimeters were connected to low noise electronics 
which allowed for the detection of lineal energies as low as 0.15 keV/μm in tissue. The silicon 
microdosimeters provide extremely high spatial resolution and can be used for in‐field and out‐of‐field 
measurements in both passive scattering and PBS deliveries. The response of the microdosimeters was 
studied in 290 MeV/u 12C, 180 MeV/u 14N, 400 MeV/u 16O passive ion beams, and 290 MeV/u 12C 
scanning carbon therapy beam at heavy ion medical accelerator in Chiba (HIMAC) and Gunma University 
Heavy Ion Medical Center (GHMC), Japan, respectively. The microdosimeters were placed at various 
depths in a water phantom along the central axis of the ion beam, and at the distal part of the Spread Out 
Bragg Peak (SOBP) in 0.5 mm increments. The RBE values of the pristine Bragg peak (BP) and SOBP were 
derived using the microdosimetric lineal energy spectra and the modified microdosimetric kinetic model 
(MKM), using MKM input parameters corresponding to human salivary gland (HSG) tumor cells. Geant4 
simulations were performed in order to verify the calculated depth‐dose distribution from the treatment 
planning system (TPS) and to compare the simulated dose‐mean lineal energy to the experimental 
results. 
Results 
For a 180 MeV/u 14N pristine BP, the dose‐mean lineal energy obtained with two types of silicon 
microdosimeters started from approximately 29 keV/μm at the entrance to 92 keV/μm at the BP, with a 
maximum value in the range of 412 to 438 keV/μm at the distal edge. For 400 MeV/u 16O ions, the 
dose‐mean lineal energy started from about 24 keV/μm at the entrance to 106 keV/μm at the BP, with a 
maximum value of approximately 381 keV/μm at the distal edge. The maximum derived RBE10 values for 
14N and 16O ions were found to be 3.10 ± 0.47 and 2.93 ± 0.45, respectively. Silicon microdosimetry 
measurements using pencilbeam scanning 12C ions were also compared to the passive scattering beam. 
Conclusions 
These SOI microdosimeters with well‐defined three‐dimensional (3D) SVs have applicability in 
characterizing heavy ion radiation fields and measuring lineal energy deposition with sub‐millimeter 
spatial resolution. It has been shown that the dose‐mean lineal energy increased significantly at the distal 
part of the BP and SOBP due to very high LET particles. Good agreement was observed for the 
experimental and simulation results obtained with silicon microdosimeters in 14N and 16O ion beams, 
confirming the potential application of SOI microdosimeter with 3D SV for quality assurance in charged 
particle therapy. 
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Abstract 27 
Background: The aim of this study was to measure the microdosimetric distributions of a carbon pencil-beam 28 
scanning (PBS) and passive scattering system as well as to evaluate the relative biological effectiveness (RBE) 29 
of different ions, namely 12C, 14N and 16O, using a silicon-on-insulator (SOI) microdosimeter with well-defined 30 
3D sensitive volumes (SV). Geant4 simulations were performed with the same experimental setup and results 31 
were compared to the experimental results for benchmarking.   32 
Method: Two different silicon microdosimeters with rectangular parallelepiped and cylindrical shaped SVs, 33 
both 10 µm in thickness were used in this study. The microdosimeters were connected to low noise electronics 34 
which allowed for the detection of lineal energies as low as 0.15 keV/μm in tissue. The silicon microdosimeters 35 
provide extremely high spatial resolution and can be used for in-field and out-of-field measurements in both 36 
passive scattering and PBS deliveries. The response of the microdosimeters was studied in 290 MeV/u 12C, 180 37 
MeV/u 14N, 400 MeV/u 16O passive ion beams, and 290 MeV/u 12C scanning carbon therapy beam at Heavy Ion 38 
Medical Accelerator in Chiba (HIMAC) and Gunma University Heavy Ion Medical Center (GHMC), Japan, 39 







ion beam, and at the distal part of the Spread Out Bragg Peak (SOBP) in 0.5 mm increments. The RBE values of 41 
the pristine Bragg peak (BP) and SOBP were derived using the microdosimetric lineal energy spectra and the 42 
modified microdosimetric kinetic model (MKM), using MKM input parameters corresponding to human salivary 43 
gland (HSG) tumour cells. Geant4 simulations were performed in order to verify the calculated depth-dose 44 
distribution from the treatment planning system (TPS) and to compare the simulated dose-mean lineal energy to 45 
the experimental results.  46 
Results:  47 
For a 180 MeV/u 14N pristine BP, the dose-mean lineal energy  obtained with two types of silicon 48 
microdosimeters started from approximately 29 keV/µm at the entrance to 92 keV/µm at the BP, with a 49 
maximum value in the range of 412 to 438 keV/µm at the distal edge. For  400 MeV/u 16O ions, the dose-mean 50 
lineal energy  started from about 24 keV/µm at the entrance to 106 keV/µm at the BP, with a maximum value 51 
of approximately 381 keV/µm at the distal edge. The maximum derived RBE10 values for 
14N and 16O ions were 52 
found to be 3.10 ± 0.47 and 2.93 ± 0.45, respectively. Silicon microdosimetry measurements using pencil beam 53 
scanning 12C ions were also compared to the passive scattering beam.   54 
Conclusions: These SOI microdosimeters with well-defined 3D SVs have applicability in characterising heavy 55 
ion radiation fields and measuring lineal energy deposition with sub-millimetre spatial resolution. It has been 56 
shown that the dose-mean lineal energy increased significantly at the distal part of the BP and SOBP due to very 57 
high LET particles. Good agreement was observed for the experimental and simulation results obtained with 58 
silicon microdosimeters in 14N and 16O ion beams, confirming the potential application of SOI microdosimeter 59 
with 3D SV for quality assurance in charged particle therapy.  60 
1. Introduction 61 
Particle therapy is particularly advantageous for the treatment of solid tumors compared to 62 
conventional electron and photon therapy due to a highly localized energy deposition. Therapeutic ion 63 
beams offer a depth dose distribution with a pronounced maximum Bragg peak (BP) and sharp dose 64 
fall-off at large penetration depths, in contrast to the exponential dose deposition of photons or the 65 
broad maximum produced by electrons. Heavier ions such as carbon, nitrogen and oxygen have further 66 
advantages over protons and lighter ions for treating deep-seated radio-resistant tumours due to an 67 
increased relative biological effectiveness (RBE) in the stopping region at the BP, while sparing the 68 
normal tissue surrounding the tumour.  69 
The potential limitations of using different particles species for cancer treatment have been 70 
discussed by Tommasino [1]. Oxygen ions are considered particularly promising due to an enhanced 71 
RBE in the target and are especially useful for the treatment of hypoxic tumours. However higher 72 
entrance dose remains a drawback when using heavier ions [1]. Moreover, heavier ions require more 73 
sophisticated treatment planning systems due to a strong rise in RBE that corresponds to an increased 74 
ionisation density in the individual tracks of the heavy charged particles [2]. Furthermore, it was 75 
shown that the maximum RBE of ions does not necessarily coincide with the maximum physical dose 76 
of the BP but it is shifted to greater LET values for heavier ions with increasing atomic numbers [2]. 77 
Therefore it is important to evaluate the maximum RBE value depending on the ion energy and atomic 78 
number and its relation to the BP position to accurately prescribe the biological dose to be delivered to 79 
the tumour.  80 
Various types of detectors can be used to measure microdosimetric quantities and derive RBE in 81 
heavy ion charged particle fields using radiobiological models. A conventional microdosimeter uses a 82 
tissue equivalent proportional counter (TEPC) that incorporates a spherical SV filled with tissue 83 
equivalent gas that model a micron sized biological cells using low pressure gas. While the TEPC is 84 
the gold standard for microdosimetry its large physical size means that spatial resolution is limited, 85 
with the addition of pile up effects in therapeutic ion beams. Additionally, the TEPC’s high voltage 86 
bias and gas supply requirements make it less ideal for routine QA in clinical environments. For this 87 
reason, experimental microdosimetric parameters have never been obtained at the Bragg peak and its 88 
distal part with high spatial resolution using a conventional TEPC.  89 
Recently, a miniature TEPC developed by the group at INFN Legnaro laboratories was proposed 90 
to avoid pile up and assess the RBE of the radiation by linking the physical microdosimetric 91 







microdosimetric measurements for both in-field and out-of-field  in low dose rate 12C and 7Li ion 93 
pencil beams have also been reported [4, 5] 94 
Solid state microdosimeters have been under development for the last two decades. A silicon 95 
monolithic E-E detector with a very thin 1.8 um E-stage and 500 um thick E–stage as well as a 96 
pixelated E stage were introduced at Politechnico di Milano, Italy, and have been described and 97 
applied for neutron microdosimetry [6] and in proton therapy for RBE evaluation in a distal part of the 98 
Bragg peak [7] utilizing E stage for LET measurements and E stage for recoil proton energy 99 
measurements (up to 8 MeV) followed by tissue equivalent correction of LET spectrum event by 100 
event. 101 
Silicon on insulator (SOI) microdosimetry was introduced at the Centre for Medical Radiation 102 
Physics (CMRP), University of Wollongong, Australia and is based on an array of micron sized 103 
sensitive volumes (SV) mimicking the dimensions of cells. These microdosimeters are used for 104 
determining the energy deposited event by event produced by primary and secondary charged 105 
particles. The SOI microdosimeter has the advantages of having a small SV size (of the order of 10 106 
µm thickness), low operational bias (5-10 V) and a high spatial resolution of the order of 100 µm 107 
which is limited by the accuracy of placing the microdosimeter in a phantom. Progress in the 108 
development of SOI microdosimeters at the CMRP and monolithic silicon E-E detectors for 109 
microdosimetry and their applications in proton, heavy ion and neutrons fields were well outlined in 110 
[8] and references within. 111 
In this paper we present measurements taken with two silicon-on-insulator (SOI) 112 
microdosimeters, consisting of an array of freestanding 3D sensitive volumes (SVs). The 113 
microdosimeters have the size of the order of cellular dimensions with a 10µm thickness, known as the 114 
Bridge and Mushroom microdosimeters. The microdosimeters were used to measure the dose-mean 115 
lineal energy deposition profiles for 12C, 14N and 16O ion fields with sub-hundred micron spatial 116 
resolution close to and at the distal part of the BP and SOBP. Such precise measurements cannot be 117 
achieved using the conventional tissue equivalent proportional counter (TEPC) due to its large 118 
physical size. The microdosimetric spectra obtained with the SOI microdosimeter at various depths in 119 
water for different ions are presented and compared to Geant4 simulation results. The newly 120 
developed mushroom microdosimeter could also operate in a high dose rate scanning beam of 290 121 
MeV/u 12C ions without pile-up problems, with the dose-mean lineal energy deposition profiles in 122 
water being successfully obtained. Measured dose-mean lineal energy for different ion species and 123 
based on that the RBE10 values corresponding to 10% of human salivary gland (HSG) cell survival 124 
calculated based on the modified microdosimetric kinetic model are also presented.  125 
2. Materials and Methods 126 
2.1  SOI microdosimeters and MicroPlus probe 127 
Two types of silicon-on-insulator (SOI) microdosimeters were used in this study. The first 128 
microdosimeter design is called the “bridge” microdosimeter, consisting of an array of 4248  3D mesa 129 
30 × 30 × 10 µm3 parallelepiped SVs, fabricated on n-type SOI wafers. The silicon surrounding the 130 
SVs was removed using plasma etching technology to avoid any charge sharing between adjacent 131 
SVs. Its charge collection properties and response to therapeutic ion beam has been studied thoroughly 132 
in [9, 10]. The second device is called the “mushroom” microdosimeter and is based on 2500 full 3D 133 
cylindrical SVs with diameter of 30 µm and 18 µm and height of 9.1 µm, fabricated on p-type SOI 134 
wafer utilising the 3D detector technology [11]. Similar to the bridge microdosimeter, the silicon 135 
surrounding the cylindrical volumes has been etched away using the deep reactive ion etching (DRIE) 136 
technique. Fig. 1a shows the bridge microdosimeter mounted on a dual in line (DIL) package and a 137 
scanning electron microscope (SEM) image of a section of the microdosimeter, revealing the straight 138 
parallelepiped shape SVs. A diagram of a single SV of the mushroom microdosimeter and its SEM 139 
image are shown in Fig. 1b and 1c, respectively. The intention of comparing the response of the two 140 
microdosimeters in this work was to understand the effect of SV shapes on the microdosimetric 141 
spectra and dose-mean lineal energy as well as to introduce the new 3D mushroom microdosimeter for 142 
















































































 a) The micro
e µ+ probe in
e 2a shows 
based on a
opy-based 
 detector to 
to the electro





 of the wate
 in the phan
d using a P
the microdo












 a)                    
 microdosim
ht). b) Schem


















 ion was de
r was used u




ng a 290 Me
g the directi
lished, the 
 of this work
 
                        
eter chip in D
atic of a sin
ushroom micr














e beam was 
















cted to the sh
be, named t
 with an a
dout electro
ry out of th
vered by a P
 with 14N an
e BP beam
 (HIMAC),
 86 mm thic
r equivalent













  b)                  
eft) and SEM
l SV of the 
lus probe - µ
aping amplifi
he Micro Pl
rray of 3D 
nics of the 
e primary ra
MMA shea
d 16O ion pr
s were delive





o a 10 × 10 
.  




 MeV/u 12C i
nma Unive
th an alumin
 of the spot
lation result
                        




us probe  (
SVs conne
+ probe is 
diation field
th to allow t
istine BP an















s of the m
                 c) 
 bridge micro
icrodosimeter
 to the micro
), develop
cted to a lo
located 10 
 and avoid 
he microdos





/u 16O in w
t the same 
ng a brass c
 an Al ridge









, c) SEM 
 
dosimeter 






m line at 
tream to 














































































































ality of a he
onsiders the
onte Carlo s





/u 12C ion ra
pectrum of 









b, c), with 
th 0.1 mm in
tal setup of t
n a water pha
water column
on and analy































he µ+ probe i
ntom. b) The







 is used to 
ck, given by
in a SV with
is to use th
m makes th
 of the char
 It was foun
n to the cal




 along the B
ents f(y) for
diation can b
n d(y) is giv
e latter is us
on field of i
ng to 10% 
 using the M















e use of <l>
ged particle
d in [12] th
culated <lPa
















dent on the 
d Gunma exp
serted into a 
ith an Amp
ement syste


















ine the  p
sed later as 
ary gland 
n be found i
he + probe









osition in a 





























is work we 
of <l>.  Th
ng SOI desi
V and is de

















nted on a 


















































































































s well as fo
ary 14N and
circular bea







d by a partic
eir deposite
 simulation 










 in  value




































 part of the 
s obtained w
rticles towa
 the SOI mi
 derived RB
red at the sa
10 reached t
led RBE10 v


























 values of ap
e BP (49.5
BP for the
ith the two d



















n where in 
and 108 bef















nd in the dis
r it was po
ion obtained
 using a pin
 value of 3
BP can be 
V/µm. Add
um   of
















, with any e










tal part of th
ssible to cle












n in figure 4
hich was th
tterer and th
of the 14N a
%, respectiv
 the detecto
r the BP, re
e higher. T
eter’s SV s








m at 19.5 m
ose  up to 4
icrodosimet
t of the BP w

































as due to a 
o the extrem
se transition
 water as w
r. It can be 
before the m







 such as 
lled with 
o form a 
d to a 10 
was 180 
mber of 









 with the 
m. Both 
 water to 




s in   




  was 
tely 2.0. 









                                                    c) 257 
Figure 5 a) Dose-mean lineal energy , b) RBE10 distribution obtained with the bridge and 258 
mushroom microdosimeters (µ+ probe) as a function of depth in water for the 180 MeV/u 14N pristine 259 
BP and c) detailed view of RBE10 distribution.  260 
Figure 6 Microdosimetric spectra obtained with the µ+ probe (mushroom microdosimeter) at 261 
different depths in a water phantom for passively delivered 180 MeV/u 14N ion pristine BP. 262 
Fig. 6 shows the microdosimetric spectra obtained with the µ+ probe (mushroom microdosimeter) 263 
along the central axis of the 14N ion pristine BP.  Measurements were taken at depths of 49, 49.5, 50, 264 
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Figure 8 a) Experimental and simulation results of dose-mean lineal energy  and b) RBE10 distribution 
obtained with the mushroom microdosimeters (µ+ probe)  as a function of depth in water for the 400 MeV/u 16O 





Figure 9 Microdosimetric spectra obtained with the µ+ probe (mushroom microdosimeter) at different depths a) 294 
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